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esenchymal cells can differentiate into osteoblasts,
adipocytes, myoblasts, or chondroblasts. Whether
mesenchymal cells that have initiated differentiation
along one lineage can transdifferentiate into another is
largely unknown. Using 3T3-F442A preadipocytes, we
explored whether extracellular signals could redirect their
differentiation from adipocyte into osteoblast. 3T3-F442A
cells expressed receptors and Smads required for bone
morphogenetic protein (BMP) signaling. BMP-2 increased
proliferation and induced the early osteoblast differentiation
 
marker alkaline phosphatase, yet only mildly affected
adipogenic differentiation. Retinoic acid inhibited adipose
conversion and cooperated with BMP-2 to enhance prolifer-
ation, inhibit adipogenesis, and promote early osteoblastic
M
 
differentiation. Expression of BMP-RII together with BMP-RIA
or BMP-RIB suppressed adipogenesis of 3T3-F442A cells
and promoted full osteoblastic differentiation in response
to retinoic acid. Osteoblastic differentiation was characterized
by induction of cbfa1, osteocalcin, and collagen I expression,
and extracellular matrix calciﬁcation. These results indicate
that 3T3-F442A preadipocytes can be converted into fully
differentiated osteoblasts in response to extracellular signaling
cues. Furthermore, BMP and retinoic acid signaling cooperate
to stimulate cell proliferation, repress adipogenesis, and
promote osteoblast differentiation. Finally, BMP-RIA and
BMP-RIB induced osteoblast differentiation and repressed
adipocytic differentiation to a similar extent.
 
Introduction
 
Mesenchymal cells can differentiate into adipocytes, myo-
cytes, chondrocytes, or osteoblasts (Prockop, 1997; Pittenger
et al., 1999). How far mesenchymal cells that have initiated
differentiation along one defined lineage can be persuaded
to transdifferentiate into another lineage is largely unknown.
This basic question is of interest to understand not only the
regulation of cell fate decisions, but also the etiology of clinical
syndromes resulting from misregulation of mesenchymal
differentiation. Of particular interest is the regulation of
osteoblast versus adipocyte differentiation in the bone mar-
row. Marrow stromal cell cultures demonstrate the ability of
single cell clones to differentiate into osteoblasts, chondro-
cytes, or adipocytes (Muraglia et al., 2000; Satomura et al.,
2000). Additionally, an inverse relationship between osteo-
blast and adipocyte differentiation has been observed (Beresford
et al., 1992). Under conditions leading to bone loss, e.g.,
osteoporosis or osteopenia, the decreased osteoblast number
correlates with increased adipocyte differentiation (Meunier
et al., 1971; Benayahu et al., 2000), suggesting that adipo-
cytes are generated at the expense of osteoblasts from a com-
mon precursor. This hypothesis is supported by the isolation
of single cell clones from bone marrow that can differentiate in
vitro into either adipocytes or osteoblasts (Park et al., 1999).
Essential to a cell’s commitment to a differentiation lin-
eage are the activation of defined transcription factors and
repression of others, thus setting the stage for a gene expres-
sion pattern characteristic for that particular cell type (Black
and Olson, 1998; de Crombrugghe et al., 2000; Rosen et al.,
2000; Wagner and Karsenty, 2001). Osteoblastic differenti-
ation is characterized by expression of alkaline phosphatase
as an early preosteoblastic marker, later expression of the
transcription factor CBFA1 that drives osteoblastic differen-
tiation and the CBFA1 target gene osteocalcin, enhanced
collagen I expression, and eventually, calcification of the
ECM (Wagner and Karsenty, 2001). Differentiation of adi-
pocytes is initiated through the transcription factors C/EBP
 
 
 
and C/EBP
 
 
 
 that activate expression of the nuclear receptor
PPAR
 
 
 
 (Wu et al., 1996; Clarke et al., 1997). PPAR
 
 
 
, as
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a heterodimer with RXR, another nuclear receptor, then
drives differentiation into lipid-filled, fully differentiated
adipocytes (Tontonoz et al., 1994a).
Ectopic expression of the specific transcription factors as-
sociated with bone or fat differentiation can activate their re-
spective differentiation programs in mesenchymal cells.
Ectopic CBFA1 expression in fibroblasts induces early os-
teoblastic differentiation (Xiao et al., 1999), but it is not
known whether CBFA1 expression in mesenchymal, nonos-
teoblast cell types (e.g., myoblasts and preadipocytes) can in-
duce osteoblastic differentiation. Similarly, ectopic expres-
sion of PPAR
 
 
 
 or C/EBP in fibroblasts and some other
mesenchymal cells leads to adipocyte differentiation (Ton-
tonoz et al., 1994b; Hu et al., 1995; Yeh et al., 1995), al-
though it is not known whether osteoblasts can be converted
into adipocytes by expressing PPAR
 
 
 
.
Signaling by cell–cell contacts, ECM proteins, and se-
creted differentiation factors, plays a key role in the selection
of a differentiation pathway and in progression of differenti-
ation. Among these, the TGF-
 
 
 
 family of growth factors
plays determinant roles in mesenchymal tissue differentia-
tion. For example, myostatin regulates muscle development
(McPherron et al., 1997), whereas bone morphogenetic pro-
teins (BMPs)* and TGF-
 
 
 
 regulate skeletal development
and homeostasis (Alliston and Derynck, 2000; Hoffmann
and Gross, 2001). Some of these functions can be studied in
cell culture. Thus, TGF-
 
 
 
 inhibits differentiation of myo-
blasts (Massagué et al., 1986; Olson et al., 1986; Liu et al.,
2001), preadipocytes (Ignotz and Massagué, 1985; Choy et
al., 2000), and osteoblasts (Centrella et al., 1994; Alliston et
al., 2001) in culture. Additionally, BMP-2, -4, and -7 in-
duce expression of alkaline phosphatase and CBFA1 in fi-
broblasts and myoblasts, and full osteoblastic differentiation
of preosteoblasts (Li et al., 1996; Lecanda et al., 1997),
whereas BMP-7–transduced fibroblasts can form bone in
vivo (Krebsbach et al., 2000).
TGF-
 
 
 
 ligands signal through two types of transmem-
brane serine–threonine kinase receptors. BMP-2 and -4 sig-
nal through the type II receptor, BMP-RII, in combination
with the type I receptors, BMP-RIA or BMP-RIB, encoded
by different genes (ten Dijke et al., 1994; Rosenzweig et al.,
1995). BMP-RIA and -RIB have been shown to stimulate
osteoblastic differentiation in preosteoblastic cell lines (Ishi-
dou et al., 1995; Fujii et al., 1999). However, studies in bi-
potential 2T3 calvarial cells proposed that BMP-RIA pro-
motes adipocyte differentiation and BMP-RIB promotes
osteoblast differentiation (Chen et al., 1998). Ligand bind-
ing results in type II receptor–mediated activation of the
type I receptors, which in turn phosphorylate and thereby
activate “receptor-activated” Smads (Massagué and Wotton,
2000). BMPs activate Smad1, Smad5, and Smad8, and
TGF-
 
 
 
 signals primarily through Smad2 and Smad3. The
receptor-activated Smads trimerize with Smad4, a compo-
nent of both the TGF-
 
 
 
 and BMP signaling pathways, and
translocate into the nucleus, where they cooperate with se-
quence-specific transcription factors to regulate gene expres-
sion in response to ligand. Smad3 acts as a key component
of TGF-
 
 
 
–induced repression of adipocyte differentiation
(Choy et al., 2000), and represses CBFA1 activity to inhibit
osteoblastic differentiation by TGF-
 
 
 
 (Alliston et al., 2001).
Another signaling system that regulates mesenchymal cell
differentiation is triggered by retinoic acid. Activation of the
nuclear retinoic acid receptor and its combination with RXR
initiates transcriptional activation of target genes. Retinoic
acid is a potent inhibitor of adipocyte differentiation, in part
through inhibition of C/EBP
 
 
 
 transcription (Schwarz et al.,
1997), an upstream regulator of PPAR
 
 
 
 transcription. Addi-
tionally, retinoic acid can also enhance osteoblast differentia-
tion through induction of alkaline phosphatase, osteocalcin,
and osteopontin expression (Choong et al., 1993; Sodek et
al., 1995).
Little is known about the ability of extracellular signals to
induce transdifferentiation from one mesenchymal lineage
into another. BMP-2/4 can induce early osteoblastic charac-
teristics in C2C12 myoblasts (Katagiri et al., 1994; Aoki et
al., 2001). Also, ectopic BMP receptor and Smad1 or
Smad5 expression in C2C12 myoblasts leads to alkaline
phosphatase expression, but not full osteoblastic differentia-
tion with ECM calcification (Akiyama et al., 1997; Yama-
moto et al., 1997). It is not known whether preadipocytes
can be converted into osteoblasts in response to BMPs or
any other extracellular stimuli.
In this paper, we evaluated the ability of preadipocytes to
differentiate into osteoblasts in response to BMP signaling.
As a model system, we used 3T3-F442A cells (Green and
Kehinde, 1976), a well-characterized preadipocyte cell line.
These cells robustly differentiate into adipocytes in vitro,
yield a fully differentiated fat pad after subcutaneous injec-
tion into nude mice (Green and Kehinde, 1979; Mandrup
et al., 1997), and are not known to differentiate into another
cell type. We demonstrate that these cells respond to BMP-2
and that increased BMP signaling represses insulin-stimu-
lated adipocyte differentiation and induces expression of os-
teoblast differentiation markers. BMP signaling and retinoic
acid cooperate to strongly repress adipocyte differentiation,
stimulate proliferation, and induce osteoblast differentiation
markers at high levels. The cooperation of retinoic acid and
BMP signaling results in transdifferentiation of the preadi-
pocytes into fully differentiated osteoblasts with ECM calci-
fication in culture. BMP-RIA and BMP-RIB signaling had
similar abilities to inhibit adipocyte differentiation and in-
duce osteoblast differentiation.
 
Results
 
3T3-F442A preadipocytes have a functional 
BMP signaling pathway
 
3T3-F442A preadipocytes, a widely used model for adipocyte
differentiation, fully differentiate into adipocytes after 8 d of
insulin treatment. Because BMP signaling has been shown to
promote osteoblastic differentiation of several mesenchymal
cell lines, we evaluated the presence of the BMP signaling ef-
fectors in 3T3-F442A cells. As shown in Fig. 1 A, 3T3-F442A
cells expressed mRNAs for BMP-RII, BMP-RIA, and BMP-
RIB, both before and after adipocyte differentiation at 8 d af-
ter reaching confluence. All three BMP receptor genes were
expressed as two mRNA species, which is consistent with pre-
vious reports (Nohno et al., 1995; Namiki et al., 1997). Al-
 
*Abbreviation used in this paper: BMP, bone morphogenetic protein. 
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though BMP-RII mRNAs remained unchanged, the BMP-
RIA and -RIB mRNA levels slightly decreased during adipo-
cyte differentiation (Fig. 1 A). The BMP receptors could not
be detected using available antibodies (unpublished data).
BMPs transduce signals through activation of Smad1, 5,
and 8 (Hoodless et al., 1996; Nakayama et al., 1998; Nish-
imura et al., 1998). In addition, BMPs induce the expres-
sion of Smad6 (Takase et al., 1998), which acts as an inhibi-
tory Smad for BMP signals (Hata et al., 1998). Although we
did not detect Smad8 mRNA expression, 3T3-F442A cells
expressed mRNAs for Smad1 and Smad5, as well as Smad6
(Fig. 1 B). Smad1 mRNA levels were similar in undifferenti-
ated and differentiated cells, but Smad5 mRNA expression
increased and Smad6 mRNA levels decreased with adipo-
genic differentiation. Together, these data suggest the pres-
ence of a fully operative BMP signaling pathway with BMP
receptors and BMP Smads in 3T3-F442A cells.
In addition to promoting osteoblastic differentiation,
BMP signaling can also enhance proliferation of mesenchy-
mal cells (Chen et al., 1991; Yamaguchi et al., 1991; Lou et
al., 1999). Therefore, we treated 3T3-F442A cells with
BMP-2 and measured the proliferation response using a
[
 
3
 
H]thymidine incorporation assay. As shown in Fig. 2,
BMP-2 increased the rate of DNA synthesis in a dose-depen-
dent manner. These results establish the existence of a func-
tional BMP-2 signaling pathway in 3T3-F442A cells.
 
Effects of BMP-2 and retinoic acid 
on adipogenic differentiation
 
Because 3T3-F442A cells expressed BMP signaling effec-
tors and responded to BMP-2, we assessed the effect of
BMP-2 on the differentiation of these preadipocytes (Fig.
3). BMP-2 altered the appearance of the cells, resulting in
an elongated, fibroblastic or osteoblastic appearance (Fig. 3
A, panel c), different from the rounder appearance of un-
treated 3T3-F442A cells (Fig. 3 A, panel a). BMP-2 also
slightly enhanced the low level of adipogenic conversion in
the absence of insulin (Fig. 3 A, panel c vs. panel a). Treat-
ment of 3T3-F442A cells with insulin induced adipogenic
differentiation with accumulation of lipid and full differen-
tiation after 8 d (Fig. 3 A, panel b). BMP-2 mildly inhib-
ited adipocyte differentiation in the presence of insulin, as
assessed by the number of lipid-containing cells using light
microscopy (Fig. 3 A, panel d). The adipogenic differentia-
tion in the presence of insulin was also evaluated using Oil
Red O staining of lipid accumulation, and the mild inhibi-
tion of adipogenic differentiation by BMP-2 was also ap-
parent in this assay (Fig. 3 B). BMP-2 treatment also con-
ferred a decrease in mRNA expression of PPAR
 
 
 
 and
adipsin, a late marker of adipocyte differentiation (Fig. 3 C).
Thus, BMP-2 signaling mildly inhibited insulin-induced
adipocyte differentiation.
Because retinoic acid inhibits adipocyte differentiation in
culture, including differentiation of 3T3-F442A cells (Kuri-
Harcuch, 1982; Schwarz et al., 1997), we evaluated the ef-
fect of retinoic acid on adipogenic differentiation in the ab-
sence or presence of BMP-2. Retinoic acid induced a fibro-
blastic morphology (Fig. 3 A, panel e) similar to BMP-2,
and strongly inhibited the ability of 3T3-F442A cells to un-
dergo adipocyte differentiation in the presence of insulin
(Fig. 3 A, panel f). This inhibition was apparent by a reduc-
tion of lipid-filled adipocytes seen microscopically (Fig. 3 A,
panel f) and after Oil Red O staining of lipids (Fig. 3 B).
Consistent with these results, retinoic acid inhibited the ex-
pression of PPAR
 
 
 
 and adipsin mRNA (Fig. 3 C).
Combination treatment of BMP-2 and retinoic acid on
3T3-F442A cells was also investigated. In the absence of
insulin, BMP-2 and retinoic acid induced a more pro-
nounced elongated, fibroblastic appearance than either
component alone, suggesting cooperation between BMP-2
and retinoic acid signaling (Fig. 3 A, panel g). In the pres-
ence of insulin, the combination of both ligands was suffi-
cient to prevent adipogenesis, as assessed morphologically
(Fig. 3 A, panel h) and using Oil Red O staining (Fig. 3
B). The combination of BMP-2 and retinoic acid did not
decrease the expression of PPAR
 
 
 
 mRNA beyond what
was seen with BMP-2 alone (Fig. 3 C). However, their
combined inhibitory effect on adipsin mRNA expression
Figure 1. Expression of BMP signaling effectors in 3T3-F442A 
cell, as assessed by Northern blotting. (A) Detection of mRNAs 
for BMP-RII, BMP-RIA, and BMP-RIB in mRNA isolated from 
3T3-F442A preadipocytes before (pread) and after (ad) adipocyte 
differentiation. The mRNA sizes are marked. (B) Detection of mRNA 
for Smad1, 5, and 6 in confluent 3T3-F442A preadipocyte and 
adipocyte cells.
Figure 2. Effect of BMP-2 on 3T3-F442A cell proliferation. 
Cells were treated with indicated concentrations of BMP-2 and 
the levels of [
3H]thymidine incorporation were determined by 
liquid scintillation counting. 
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was striking (Fig. 3 C), and consistent with a synergy of
BMP-2 and retinoic acid signaling.
 
BMP-2 and retinoic acid induce alkaline phosphatase 
expression and cooperate
 
The reported ability of BMP-2 to promote osteoblastic dif-
ferentiation led us to evaluate the effect of BMP-2 on the
expression of alkaline phosphatase, an early marker of os-
teoblast differentiation. As can be seen in Fig. 4 A, BMP-2
induced the expression of alkaline phosphatase in confluent
3T3-F442A cells in a dose-dependent manner, suggesting
that these cells have the potential to transdifferentiate to
osteoblasts. Cotreatment with insulin, which promotes adi-
pogenesis, did not repress the expression of alkaline phos-
phatase. Instead, insulin minimally but consistently en-
hanced the induction of alkaline phosphatase expression by
BMP-2 (Fig. 4 B), even though the cells were undergoing
nearly quantitative adipose conversion (Fig. 3, A and B).
BMP-2 did not induce an advanced osteoblastic pheno-
type, which was apparent from the absence of cbfa1 or os-
teocalcin mRNA expression (unpublished data). Preosteo-
blasts can undergo full osteoblast differentiation with ECM
 
mineralization, when cultured as confluent monolayers in
the presence of 
 
 
 
-glycerophosphate and ascorbic acid for
extended periods. However, also under these conditions
did we not detect cbfa1 or osteocalcin mRNA expression,
and we did not observe mineralization of the ECM (un-
published data).
Because retinoic acid inhibited adipocyte differentiation
and can enhance osteoblast differentiation (Choong et al.,
1993; Sodek et al., 1995), we determined its effect on osteo-
blast differentiation of 3T3-F442A cells. Enzymatic assays
revealed that retinoic acid induced a dose-dependent in-
crease in alkaline phosphatase activity, which was already ap-
parent at a level of 1 nM (Fig. 4 C). Treatment with 1 
 
 
 
M
retinoic acid induced a sixfold increase over basal activity.
Thus, retinoic acid both suppressed adipocyte differentia-
tion and promoted expression of an early osteoblast marker.
However, continuous treatment with 1 
 
 
 
M retinoic acid,
even in the presence of 
 
 
 
-glycerophosphate and ascorbic
acid, failed to yield cbfa1 or osteocalcin mRNA expression
or detectable mineralization (unpublished data).
Because BMP-2 and retinoic acid signaling cooperated to
suppress adipocyte differentiation, we assessed their com-
Figure 3. Effects of insulin, BMP-2, and retinoic acid treatments on 3T3-F442A cell morphology, lipid accumulation, and adipocyte gene 
expression. (A) Morphology of 3T3-F442A cells, cultured in the presence of 10% FBS, in the absence (a, c, e, and g) or presence (b, d, f, and h) 
of 5  g/ml insulin (a and b, no addition; c and d, 100 ng/ml BMP-2; e and f, 10
 6 M retinoic acid; g and h, 100 ng/ml BMP-2 and 10
 6 M 
retinoic acid. (B) Oil Red O staining of lipids in cells cultured in the presence of 5  g/ml insulin, 100 ng/ml BMP-2, 10
 6 M retinoic acid, or 
100 ng/ml BMP-2 with 10
 6 M retinoic acid. (C) Northern blot detection of mRNAs for PPAR  and adipsin, after 8 d of insulin treatment in the 
presence or absence of BMP-2 and retinoic acid. Insulin, BMP-2, and retinoic acid were used at the same concentrations as in A and B. Ethidium 
bromide staining of RNA (bottom) demonstrates equal loading. RA, retinoic acid; Ins, insulin. 
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bined effect on osteoblastic differentiation and proliferation
of 3T3-F442A cells. 10 nM retinoic acid alone only moder-
ately induced alkaline phosphatase expression, but strongly
synergized with BMP-2 in inducing the expression of al-
kaline phosphatase (Fig. 4 D). A similar cooperativeness
was also seen when we measured the cell proliferation in
[
 
3
 
H]thymidine incorporation assays (Fig. 5). Although ret-
inoic acid alone had only a mild effect on cell proliferation,
it strongly enhanced BMP-2–induced DNA synthesis to a
level that greatly exceeded the maximum proliferation at-
tained by BMP-2 alone.
Together, these results suggest that BMPs and retinoic
acid cooperate in the regulation of mesenchymal differentia-
tion along the adipocyte and osteoblast lineages. Therefore,
we treated 3T3-F442A cells for long periods with both
ligands in the presence of 
 
 
 
-glycerophosphate and ascorbic
acid. However, these cells did not show detectable mRNA
Figure 4. Effects of BMP-2, insulin, and 
retinoic acid on alkaline phosphatase 
expression in 3T3-F442A cells. Dose-
dependent induction by (A) BMP-2, (B) 
BMP-2 with or without 5  g/ml insulin, 
(C) retinoic acid, and (D) BMP-2 with or 
without 10 nM retinoic acid. Confluent 
cells were treated with the ligands
for 48 h followed by assessment of
alkaline phosphatase activity.
Figure 5. Synergy of BMP-2 and retinoic acid in the stimulation of 
cell proliferation. Cells were treated with BMP-2 at the indicated 
concentrations in the presence or absence of 10 nM retinoic acid, 
and then the levels of cellular [
3H]thymidine incorporation were 
determined. RA, retinoic acid.
Figure 6. Western blot detection of BMP-RII, RIA, and RIB in 
stably infected 3T3-F442A cells, and effect of BMP-2 and retinoic 
acid on [
3H]thymidine incorporation. II-RIA and II-RIB cells have 
increased levels of BMP-RII and BMP-RIA and BMP-RIB, respectively, 
whereas LL cells are control-infected 3T3-F442A cells. (A) Expression 
of Flag-tagged BMP-RII and HA-tagged BMP-RIA or BMP-RIB in the 
retrovirally infected, stable 3T3-F442A cell lines. Receptors were 
immunoprecipitated with anti-Flag–conjugated beads (for BMP-RII) 
or anti-HA antibody with protein A–Sepharose beads (for BMP-RIA 
and BMP-RIB) followed by Western blotting and chemiluminescence 
detection. (B) LL and II-RIB cells were treated with BMP-2 at the 
indicated concentrations in the presence or absence of 10 nM retinoic 
acid, and then the levels of cellular [
3H]thymidine incorporation 
were determined. 
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expression of cbfa1 and osteocalcin, and we did not observe
mineralization of the ECM (unpublished data).
 
Enhanced BMP receptor signaling and retinoic acid 
cooperate to stimulate cell proliferation
 
The cooperation of BMP-2 and retinoic acid resulted in al-
kaline phosphatase expression, but not in cbfa1, osteocalcin
expression, or deposition of a mineralized matrix. Therefore,
we explored the effects of enhanced BMP sensitivity and
BMP receptor signaling by increasing the levels of BMP
receptors on adipogenic and osteoblastic differentiation.
BMP-RIA and BMP-RIB were mutated in their GS domain
to confer a low level of constitutive signaling (Hoodless et
al., 1996), which could be enhanced by addition of exoge-
nous ligand. Ectopic expression of these basally activated
BMP-RIA or -RIB, in the absence of overexpressed BMP-
RII, had little effect on differentiation (unpublished data).
Because efficient ligand binding requires both ectodomains
of BMP-RII and BMP-RIA or BMP-RIB (Liu et al., 1995;
Rosenzweig et al., 1995), we generated retrovirally infected
cells that expressed both BMP-RII and BMP-RIA or BMP-
RIB receptors. These cells, named II-RIA and II-RIB, ex-
pressed both Flag-tagged BMP-RII and HA-tagged BMP-
RIA or -RIB, with the expected sizes of 80 kD and 60 or 55
kD, respectively (Fig. 6 A). The II-RIA and II-RIB cells, as
well as the control cells, infected with empty control vectors
(LL cells), were then evaluated for their adipocytic and os-
teoblastic differentiation potential. Because II-RIA cells
behaved similarly to II-RIB cells in their differentiation char-
acteristics, we will focus our description on the characteriza-
tion of the II-RIB cells.
In the absence of added BMP-2, the rate of [
 
3
 
H]thymi-
dine incorporation of II-RIB cells was considerably above
that of control LL cells in the presence of saturating levels of
BMP-2 (Fig. 6 B). Such enhanced proliferation is consistent
with the mitogenic effect of BMP-2 on 3T3-F442A cells
(Fig. 2) and the increased sensitivity and receptor signaling
by the overexpressed BMP-RII and BMP-RIB receptors
(Hoodless et al., 1996). Addition of BMP-2 further en-
hanced the [
 
3
 
H]thymidine incorporation (Fig. 6 B). Retinoic
acid at 10 nM enhanced the proliferation of LL cells and
more strongly that of the II-RIB cells (Fig. 6 B), thereby re-
flecting a cooperativeness between retinoic acid and BMP
receptor signaling, as observed in the parental cells (Fig. 5).
The resulting proliferation rate of II-RIB cells was much
higher than what could be achieved in the parental cells.
 
BMP signaling and retinoic acid cooperate to inhibit 
adipocyte differentiation
 
Increased BMP signaling had a dramatic effect on the adipo-
cyte differentiation of these stable cells. Under adipogenic
conditions (i.e., in the presence of insulin), both II-RIA and
II-RIB cells displayed less lipid accumulation, as visualized
using Oil Red O staining, whereas LL cells had normal dif-
Figure 7. Adipocyte differentiation potential of 
stable BMP receptor–expressing cells. II-RIA and 
II-RIB cells have increased levels of BMP-RII and 
BMP-RIA and BMP-RIB, respectively, whereas LL 
cells are control-infected 3T3-F442A cells. (A) Oil 
Red O staining of lipids after 8 d of insulin treat-
ment. LL cells show a high level of adipocyte 
differentiation, whereas adipocyte differentiation 
of II-RIA and II-RIB cells is impaired. (B) mRNA 
expression of PPAR  and adipsin in LL and II-RIB 
cells, after 8 d under conditions of adipogenic 
differentiation (  insulin) or in the presence of fetal 
bovine serum. Retinoic acid and/or BMP-2 were 
added during this time, as indicated. Ethidium 
bromide staining of RNA demonstrates equal loading. 
RA, retinoic acid. 
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ferentiation characteristics (Fig. 7 A) with increased PPAR
 
 
 
and adipsin mRNA levels (Fig. 7 B, right lanes). The II-RIB
cells had only slightly lower PPAR
 
 
 
 mRNA expression than
LL cells at confluence after 8 d in the presence of insulin,
but adipsin mRNA expression was strongly inhibited (Fig. 7
B), demonstrating that BMP signaling primarily blocks the
later stages of adipogenesis.
Under these adipogenic conditions, retinoic acid cooper-
ated with the inhibitory effect of increased BMP receptor
signaling. In LL cells, retinoic acid did not affect the induc-
tion of PPAR
 
 
 
 mRNA, but inhibited adipsin mRNA ex-
pression (Fig. 7 B). In II-RIB cells, however, both genes
were strongly inhibited by retinoic acid (Fig. 7 B), much
more so than by combined retinoic acid/BMP-2 treatment
of parental cells (Fig. 3 C). Clearly, BMP and retinoic sig-
naling cooperated to inhibit the adipogenic differentiation
of II-RIB cells, and the combination of both signaling path-
ways was required to block induction of PPAR
 
 
 
 and adipsin
expression.
Under nonadipogenic conditions (i.e., in the absence of
insulin), LL cells showed a different interaction between
BMP and retinoic acid signaling. Treatment of LL cells with
BMP-2 for 8 d at confluence in the presence of serum
slightly decreased PPAR
 
 
 
 mRNA, and strongly decreased
adipsin mRNA expression, whereas retinoic acid blocked the
expression of both genes (Fig. 7, left lanes). However, in the
presence of BMP-2, retinoic acid slightly enhanced the ex-
pression of PPAR
 
 
 
 mRNA, but not adipsin mRNA (Fig. 7,
lane 5 vs. lane 3). Under nonadipogenic conditions, retinoic
acid, in the absence or presence of BMP-2, blocked PPAR
 
 
 
and adipsin mRNA expression in II-RIB cells. Thus, in-
creased BMP receptor levels profoundly affected the re-
sponse to BMP-2, with or without retinoic acid, under non-
adipogenic conditions.
 
BMP signaling and retinoic acid cooperate to confer 
full osteoblastic differentiation
 
BMP-2 and retinoic acid cooperatively induced the expres-
sion of alkaline phosphatase in parental 3T3-F442A preadi-
pocytes (Fig. 4 D). Therefore, we explored this cooperation
in osteoblastic differentiation of II-RIA and II-RIB cells. II-
RIB cells had a basal level of alkaline phosphatase expression
that was much higher than that of parental cells treated with
200 ng/ml BMP-2, i.e., 45.5 
 
 
 
 1.3 (Fig. 8 A) versus 17.4 
 
 
 
0.6 U/mg protein/h (Fig. 4 A). This activity was slightly en-
hanced by adding exogenous BMP-2, and more strongly en-
hanced by retinoic acid, with levels reaching 139.52 
 
 
 
 8.58
U/mg protein/h at 1 
 
 
 
M retinoic acid (Fig. 8 B). These ob-
servations reflect the cooperation of BMP-2 and retinoic
acid signaling in osteoblastic differentiation.
This cooperation was also apparent in the cell morphology
of II-RIB cells (Fig. 8 C). II-RIB cells had an elongated spin-
dle-like morphology when compared with the more extended
and flatter morphology of the LL cells. Addition of retinoic
Figure 8. Effects of BMP-2 and retinoic acid on osteoblastic 
differentiation of II-RIB and LL cells. (A) BMP-2 induction of alkaline 
phosphatase activity in LL and II-RIB cells. (B) Retinoic acid induction 
of alkaline phosphatase activity in LL and II-RIB cells. In A and B, 
confluent cells were treated with ligand for 48 h, and alkaline 
phosphatase activity in the cell lysates was measured. (C) Morphology 
of LL and II-RIB cells cultured for 8 d in the presence of 10
 6 M 
retinoic acid. (D) Effects of BMP-2 and retinoic acid on mRNA 
expression of the osteoblast differentiation genes, CBFA1, osteocalcin, 
and collagen type I. Ethidium bromide staining of RNA (bottom) 
demonstrates equal loading. RA, retinoic acid. 
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acid induced a mildly elongated phenotype in LL cells, and a
dense, elongated phenotype in II-RIB cells, reminiscent of
confluent osteoblast cultures, before mineralization.
Osteoblastic maturation is accompanied by induction of
expression of CBFA1 and several late marker genes such as
osteocalcin and collagen type I. Although osteocalcin is in-
volved in the formation of hydroxyapatite crystals in the
mineralization process, it is the extracellular collagen type I
matrix that is ultimately mineralized (Wagner and Karsenty,
2001). Thus, we evaluated the expression of these genes in
II-RIB cells (Fig. 8 D). Retinoic acid induced the expression
of cbfa1 mRNA in II-RIB cells, but not in LL cells. In con-
trast to LL cells, confluent II-RIB cells expressed osteocalcin
mRNA, but appeared to do so without a concomitant in-
crease in cbfa1 mRNA expression. The levels of collagen I
mRNA expression were similar in LL and II-RIB cells, but
retinoic acid strongly increased its expression in II-RIB cells,
and not in control LL cells. Together, these findings dem-
onstrate the expression of osteoblastic marker genes in II-
RIB cells, and the cooperation of retinoic acid with BMP re-
ceptor signaling in inducing the cbfa1 and collagen I gene
expression.
Finally, II-RIA, II-RIB, and control LL cells were exam-
ined for their ability to undergo ECM mineralization, when
cultured at confluence in the presence of 
 
 
 
-glycerophosphate
and ascorbic acid. Matrix mineralization was visualized using
von Kossa staining. In the absence of retinoic acid, II-RIA
and II-RIB cell cultures did not undergo mineralization. In
contrast, II-RIA and II-RIB cells both elaborated a high level
of ECM mineralization when cultured in the presence of ret-
inoic acid (Fig. 9 A). Microscopic analysis of these retinoic
acid–treated cells confirmed the presence of mineralized re-
gions (Fig. 9 B). Control LL cells did not have any matrix
mineralization, either in the absence or presence of retinoic
acid, which is similar to parental 3T3-F442A cells (unpub-
lished data). These results indicate that increased BMP re-
ceptor signaling and retinoic acid cooperate to induce full os-
teoblastic differentiation of 3T3-F442A preadipocytes.
 
Discussion
 
In this paper, we explored whether extracellular signals could
redirect cells that were destined to differentiate along the ad-
ipocyte lineage, to differentiate into osteoblasts. BMP signal-
ing is relevant for osteoblast differentiation, but in how far
BMP signaling can drive transdifferentiation from other
mesenchymal cell types to osteoblasts is unclear. C2C12 myo-
blasts can be induced to express some early osteoblast mark-
ers in response to elevated BMP signaling (Katagiri et al.,
1994; Aoki et al., 2001); however, this stimulation was inad-
equate for osteoblast differentiation and mineralization. To
explore whether BMP signaling can redirect committed
Figure 9. von Kossa staining of confluent 
LL, II-RIA, and II-RIB cells and micro-
scopic visualization of the differentiated 
osteoblast phenotype. (A) von Kossa 
staining of LL, II-RIA, and II-RIB cells, 
cultured in the presence of  -glycero-
phosphate and ascorbic acid for 25 d, in 
the absence or presence of 10
 6 M reti-
noic acid. (B) Microscopic visualization 
of LL or II-RIB cells cultured for 25 d in 
the presence of  -glycerophosphate and 
ascorbic acid, and 10
 6 M retinoic acid. 
RA, retinoic acid. 
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preadipocytes to fully differentiate into osteoblasts, we stud-
ied 3T3-F442A preadipocytes. In contrast to primary cul-
tures from adipose tissue, this cell line has defined character-
istics, is homogeneous, and is not known to differentiate into
any other cell type. The basal expression of PPAR
 
 
 
 (Choy et
al., 2000) and the differentiation into fat pads in vivo (Green
and Kehinde, 1976; Mandrup et al., 1997) reflect the com-
mitment of 3T3-F442A cells to adipogenic differentiation.
Our results allowed for several major conclusions: (1)
3T3-F442A preadipocytes express the effectors of the BMP
receptor–signaling system and respond to BMP-2; (2) BMP
receptor signaling cooperates with retinoic acid signaling to
repress adipogenesis and promote osteoblastic differentia-
tion; (3) 3T3-F442A preadipocytes can be converted into
fully differentiated osteoblasts that are able to undergo calci-
fication in cell culture; and (4) BMP-RIA and BMP-RIB are
comparable in their abilities to induce osteoblastic differen-
tiation and repress adipose differentiation.
 
3T3-F442A cells express BMP signaling mediators and 
respond to BMP-2
 
Our data demonstrate that 3T3-F442A cells express the me-
diators for a functional BMP signaling pathway. We show
that BMP-RII, -RIA, and -RIB mRNAs are present in 3T3-
F442A cells, as well as Smad1 and Smad5, and the inhibi-
tory Smad6, in addition to Smad4 as reported previously
(Choy et al., 2000). Smad5 mRNA levels were enhanced
during adipocyte differentiation, whereas Smad1 mRNA
levels were unchanged. Smad6 mRNA was down-regulated
during differentiation, similarly to the down-regulation of
Smad7 (Choy et al., 2000).
The presence of a functional BMP signaling mechanism
was also apparent from the responses of 3T3-F442A cells to
BMP-2. BMP-2 increased proliferation and induced a change
in cell shape and expression of alkaline phosphatase. The mi-
togenic response and induction of alkaline phosphatase are
consistent with the responses of some other mesenchymal cell
lines, including preosteoblasts, to BMP-2 or BMP-4 (Chen et
al., 1991; Yamaguchi et al., 1991; Lou et al., 1999).
 
Cooperation of BMP receptor and retinoic acid signaling
 
To our knowledge, our results provide the first evidence for
cooperation of retinoic acid and BMP signaling in cell dif-
ferentiation, proliferation, and gene expression. BMP-2 and
retinoic acid were shown to cooperate to induce apoptosis
(Glozak and Rogers, 1996; Rodriguez-Leon et al., 1999).
The cooperation of retinoic acid with BMP signaling re-
sulted in inhibition of adipocyte differentiation and induc-
tion of osteoblast differentiation, as well as proliferation.
This cooperation occurred at a low level of retinoic acid (10
nM), which by itself had only a minimal effect.
The cooperation in cell differentiation may, in part, result
directly from the ability of retinoic acid to inhibit adipocyte
differentiation because the strong adipogenic tendency of
3T3-F442A cells could prevent their osteoblastic potential
from being realized. Indeed, unidentified factors released by
adipocytes inhibit osteoblast activity (Maurin et al., 2000),
and blocking adipocyte differentiation by retinoic acid treat-
ment may eliminate these inhibitors. However, our results
indicate that the activity of retinoic acid to promote BMP-
induced osteoblastic differentiation goes beyond simply in-
hibiting adipocyte differentiation. For example, BMP signal-
ing and retinoic acid cooperate to induce expression of the
cbfa1 and collagen type I genes that are critical for bone
mineralization. Because retinoic acid can increase BMP ex-
pression (Gazit et al., 1993; Helvering et al., 2000; Paralkar
et al., 2002), such cooperation could result from the induc-
tion of BMP ligands by retinoic acid. However, in 3T3-
F442A cells, we did not see an increase of the low levels of
endogenous mRNAs for BMP-2, -4, and -6 in response to
retinoic acid (unpublished data), and the strong effects of re-
tinoic acid on gene expression and differentiation reflect a
more direct cooperation of these two signaling pathways. In
addition to interactions with indirect, BMP-induced tran-
scriptional responses, the activated retinoic acid receptor
could also directly interact with BMP-activated Smads to re-
press or activate transcription of genes involved in cell cycle
regulation and osteoblastic or adipocytic differentiation. Al-
though Smads are not known to interact with the retinoic
acid receptor, they can associate and cooperate with several
nuclear receptors, including the glucocorticoid, androgen,
and vitamin D3 receptors (Song et al., 1999; Yanagisawa et
al., 1999; Hayes et al., 2001). Perhaps the cooperation of re-
tinoic acid with BMP signaling may provide a mechanism
for retinoic acid–induced osteoblast differentiation observed
in some preosteoblast cell lines (Choong et al., 1993; Ko-
dama et al., 1997).
 
Preadipocytes can be converted to fully 
differentiated osteoblasts
 
Several mesenchymal cell systems respond to BMPs by in-
ducing genes that are expressed early during osteoblast dif-
ferentiation, but only preosteoblastic cells can go as far as
matrix mineralization (Li et al., 1996; Lecanda et al., 1997).
For a cell to convert from one cell type to another, there
must be suppression of differentiation of the original cell
type with promotion of differentiation to the new type. We
now show that enhancement of BMP signaling combined
with retinoic acid signaling fully converts 3T3-F442A
preadipocytes into osteoblasts, with induction of cbfa1 and
osteocalcin expression and ECM mineralization, while
blocking adipose differentiation. These results suggests that,
under physiological conditions, retinoids could cooperate
with increased BMP ligand, BMP receptor, or Smad expres-
sion to redirect preadipocytes into the osteoblastic lineage.
In parental 3T3-F442A cells, BMP-2 only weakly inhib-
ited insulin-induced adipogenesis and, in the absence of
insulin, slightly promoted adipocyte differentiation. This
weak stimulation may be due to endogenous expression of
BMP-RIA, which can promote adipogenesis in 2T3 calva-
rial cells (Chen et al., 1998), and is consistent with reports
that BMP-2 sometimes promotes or inhibits adipogenesis
(Wang et al., 1993; Gimble et al., 1995). Similar to results
in C2C12 myoblasts (Katagiri et al., 1994), BMP-2 in-
duced alkaline phosphatase expression in 3T3-F442A cells,
but did not confer a more differentiated osteoblastic phe-
notype. Furthermore, alkaline phosphatase induction by
BMP-2 was not accompanied by a reduction in adipogene-
sis; instead, cells expressing alkaline phosphate were capable
of quantitative adipose conversion. Thus, induction of alka- 
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line phosphatase is compatible with nonosteoblastic differ-
entiation, in agreement with a previous demonstration of
alkaline phosphatase expression in preadipocytes (Dorheim
et al., 1993). In fact, insulin even slightly enhanced BMP-
2–induced alkaline phosphatase expression as it promoted
adipogenesis.
Only at higher BMP receptor levels, in the retrovirally in-
fected cells, did BMP signaling strongly decrease adipocyte
differentiation, while promoting osteoblastic differentiation.
Full osteoblastic differentiation resulted from combining
retinoic acid treatment with high level BMP signaling. Un-
der these conditions, adipocyte differentiation was fully re-
pressed. Interestingly, osteocalcin was expressed in II-RIB
cells in the absence of retinoic acid, suggesting that osteocal-
cin expression is not sufficient for matrix mineralization. In-
deed, mineralization was observed only when collagen type I
expression was induced.
 
BMP-RIA and BMP-RIB both inhibit adipocyte 
and stimulate osteoblast differentiation
 
Lastly, our results provide evidence that BMP-RIA and
BMP-RIB, in combination with BMP-RII, exert similar ef-
fects on adipocyte and osteoblast differentiation of 3T3-
F442A cells. Our observations seem to contrast with a previ-
ous conclusion, obtained using the calvarial 2T3 cell line,
that signaling through BMP-RIB promotes osteoblast differ-
entiation, whereas signaling through BMP-RIA promotes
adipocyte differentiation (Chen et al., 1998). Because both
receptors are expressed in 3T3-F442A cells, it is conceivable
that conflicting signals by these two receptors could contrib-
ute to the inability of BMP ligand to promote terminal os-
teoblast differentiation. However, 3T3-F442A cells, stably
expressing either activated BMP-RIA or -RIB, along with
BMP-RII, showed a similar inhibition of adipocyte differen-
tiation and similarly elevated levels of osteoblast differentia-
tion. They also exhibited similar proliferation rates and alka-
line phosphatase expression levels, and similar cooperation
with retinoic acid (unpublished data). The comparable ac-
tivities of BMP-RIA and -RIB are consistent with their abil-
ities to activate Smad1 and 5, and to induce alkaline phos-
phatase expression in transfected C2C12 cells (Akiyama et
al., 1997). The difference in cell line and differentiation
conditions, as well as the experimental design, may have led
to the observed differences between BMP-RIA and BMP-
RIB in 2T3 versus 3T3-F442A cells. Future studies will
characterize the molecular mechanisms of the cooperation of
retinoic acid with BMP signaling through either BMP re-
ceptor system in the inhibition of adipocyte and promotion
of osteoblast differentiation.
 
Materials and methods
 
Construction of expression plasmids
 
For retroviral infection, cDNAs encoding human BMP-RII, BMP-RIA, or
BMP-RIB were subcloned in retroviral expression plasmids. The coding se-
quence for NH
 
2
 
 terminally Flag-tagged BMP-RII (a gift from J. Massagué,
Memorial Sloan-Kettering Cancer Center, New York, NY) was cloned into
LNCX (Miller and Rosman, 1989). The sequences for NH
 
2
 
 terminally HA-
tagged BMP-RIA and BMP-RIB with the activating Q233D and Q203D
mutations, respectively (Hoodless et al., 1996; gifts from L. Attisano, Uni-
versity of Toronto, Toronto, Canada) were subcloned into LPCX (Choy et
al., 2000).
 
Cell culture and generation of stable cell lines
 
The murine preadipocyte cell line 3T3-F442A (Green and Kehinde, 1976)
was purchased from H. Green (Harvard Medical School, Boston, MA). The
cells were maintained at subconfluence in DME with 10% bovine calf se-
rum (HyClone). For adipocyte differentiation, cells were grown to conflu-
ence in DME with 10% FBS (Life Technologies) and the culture medium
was supplemented with 5 
 
 
 
g/ml insulin (Sigma-Aldrich). For osteoblast dif-
ferentiation, cells were grown to confluence in DME with 10% FBS. The
culture medium was supplemented with 5 mM 
 
 
 
-glycerophosphate and
100 
 
 g/ml ascorbic acid (Sigma-Aldrich), to allow osteoblast differentia-
tion. BMP-2 was purchased from R&D Systems, and all trans-retinoic acid
was purchased from Sigma-Aldrich.
For generating recombinant expression viruses, we used Phoenix E cells
(provided by G. Nolan, Stanford University, Stanford, CA). Cells were
maintained, and retroviruses were generated and used to infect 3T3-F442A
cells by a spin-infection method, as described previously (Choy et al.,
2000). 48 h later, selection was initiated, either with 1 mg/ml G418 (Life
Technologies) or 2  g/ml puromycin (Calbiochem) as appropriate.
von Kossa staining, [
3H]thymidine incorporation, and alkaline 
phosphatase assays
Stably infected, BMP receptor–expressing 3T3-F442A cells were cultured
for 25 d in osteoblast differentiation conditions as described above. Miner-
alization of the ECM was visualized using the histochemical von Kossa
staining method (Bhargava et al., 1988).
Rates of DNA synthesis, which correlate with cell proliferation, were
determined by [
3H]thymidine incorporation assays as described previously
(Choy et al., 2000). BMP-2 and/or retinoic acid were added for 24 h before
addition of [
3H]thymidine (2 Ci/mmol; NEN Life Science Products) which
was allowed to incorporate for 3 h, followed by processing of the cell ly-
sates for liquid scintillation counting.
Alkaline phosphatase assays were performed using a Sigma-Aldrich di-
agnostic kit. Cells were seeded at a density of 50,000 cells per well of a
12-well dish, and allowed to grow to confluence for 2 d. Medium was
changed to contain BMP-2 and/or retinoic acid. After 2 d of treatment,
cells were lysed with 0.01% SDS in PBS, and the lysates were scraped and
collected. 10  l lysate was added to 100  l prewarmed PNPP substrate
and buffer mixture, and the reaction proceeded at 37 C. The reaction was
stopped by adding 1 ml 0.05 N NaOH and the OD was read at 420 nm.
Concentration of alkaline phosphatase was determined by comparison to a
PNP standard curve. All values were normalized against protein concen-
tration determined using the Bio-Rad Laboratories protein assay.
Northern blot analysis
Total RNA was isolated from 3T3-F442A cells using the SV RNA isolation
kit (Promega), whereas poly(A
 ) mRNA was isolated using the PolyA Tract
mRNA isolation kit (Promega). For Northern blot analysis, 1  g mRNA or
10  g total RNA was precipitated and separated in a 1% formaldehyde
agarose gel and blotted overnight into BioTrans membrane (ICN Bio-
medicals). 
32P-labeled cDNA probes were prepared using the random
priming oligonucleotide method (Feinberg and Vogelstein, 1983) using
 -[
32P]dCTP (6,000 Ci/mmol; NEN Life Science Products). Hybridization
and washes were performed as described previously (Ausubel et al., 1994).
For Northern blots using total RNA, equal loading was verified by ethidium
bromide staining of 18 S- and 28 S-RNA bands.
Probes used for Northern blot analysis were as follows: cDNAs for the
BMP receptors (BMP-RIA, BMP-RIB, and BMP-RII [GenBank EMBL/DDBJ
accession no. NM 004329, NM 007560, and NM 001204, respectively]
ten Dijke et al., 1994; Liu et al., 1995) were obtained from J. Massagué
and L. Attisano. Cbfa1 (GenBank EMBL/DDBJ accession no. AF010284;
Ducy et al., 1997) and osteocalcin (GenBank EMBL/DDBJ accession no.
NM 031368; Celeste et al., 1986) cDNAs were gifts from P. Ducy and G.
Karsenty (Baylor College of Medicine, Houston, TX). A collagen type I
cDNA probe was generated by RT-PCR of 3T3-F442A RNA using the
forward primer 5 -ATGTTCAGCTTTGTGGACCTCC-3  and the reverse
primer 5 -CGTATTGTTCCGGGCAGAAAGC-3  (GenBank EMBL/DDBJ
accession no. X54876). cDNAs for PPAR 2 (GenBank EMBL/DDBJ acces-
sion no. NM 015869; Tontonoz et al., 1994a) and adipsin (GenBank
EMBL/DDBJ accession no. NM 013459; Cook et al., 1985) were gifts from
B. Spiegelman (Dana Farber Cancer Institute, Harvard Medical School,
Boston, MA).
Western blot analysis
To detect Flag-tagged BMP-RII and HA-tagged BMP-RIA or -RIB, stably in-
fected 3T3-F442A cells were grown to confluence in 10-cm-diam dishes.
Cells were washed with PBS and lysed in 1 ml lysis buffer containing 25 Preadipocyte to osteoblast transdifferentiation | Skillington et al. 145
mM Tris, pH 7.5, 300 mM NaCl, 1% Triton X-100, 20  g/ml leupeptin, 10
 M PMSF, and 20  g/ml aprotinin. Flag-tagged BMP-RII was immunopre-
cipitated using anti-Flag M2 agarose affinity gel (Sigma-Aldrich). HA-
tagged BMP-RIA and -RIB were immunoprecipitated using anti-HA.11 an-
tibody (Covance, Inc.). Immunoprecipitates were analyzed by SDS-PAGE
and blotted, and the immunoprecipitated receptors were visualized by
chemiluminescence detection (Amersham Biosciences).
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